CA2621824C - Interpenetrating networks, and related methods and compositions - Google Patents
Interpenetrating networks, and related methods and compositions Download PDFInfo
- Publication number
- CA2621824C CA2621824C CA2621824A CA2621824A CA2621824C CA 2621824 C CA2621824 C CA 2621824C CA 2621824 A CA2621824 A CA 2621824A CA 2621824 A CA2621824 A CA 2621824A CA 2621824 C CA2621824 C CA 2621824C
- Authority
- CA
- Canada
- Prior art keywords
- collagen
- hydrogel
- network
- biopolymer
- corneal
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 238000000034 method Methods 0.000 title claims abstract description 31
- 239000000203 mixture Substances 0.000 title abstract description 43
- 239000000463 material Substances 0.000 claims abstract description 166
- 239000000017 hydrogel Substances 0.000 claims abstract description 134
- 229920000642 polymer Polymers 0.000 claims abstract description 51
- 229920001222 biopolymer Polymers 0.000 claims abstract description 24
- 102000008186 Collagen Human genes 0.000 claims description 135
- 108010035532 Collagen Proteins 0.000 claims description 135
- 229920001436 collagen Polymers 0.000 claims description 134
- 229920001661 Chitosan Polymers 0.000 claims description 53
- 239000007943 implant Substances 0.000 claims description 49
- 210000004087 cornea Anatomy 0.000 claims description 48
- 210000005036 nerve Anatomy 0.000 claims description 34
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 29
- 210000004027 cell Anatomy 0.000 claims description 25
- 230000012010 growth Effects 0.000 claims description 25
- 239000012867 bioactive agent Substances 0.000 claims description 23
- 229940072056 alginate Drugs 0.000 claims description 19
- 229920000615 alginic acid Polymers 0.000 claims description 19
- 238000004132 cross linking Methods 0.000 claims description 19
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical group O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 claims description 18
- 235000010443 alginic acid Nutrition 0.000 claims description 18
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 18
- 239000000178 monomer Substances 0.000 claims description 17
- 239000003814 drug Substances 0.000 claims description 16
- 229920001223 polyethylene glycol Polymers 0.000 claims description 16
- 229940079593 drug Drugs 0.000 claims description 15
- -1 fibrin-fibrinogen Polymers 0.000 claims description 14
- 229920001287 Chondroitin sulfate Polymers 0.000 claims description 11
- 239000003102 growth factor Substances 0.000 claims description 11
- 238000002513 implantation Methods 0.000 claims description 11
- 229920001059 synthetic polymer Polymers 0.000 claims description 11
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 claims description 9
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 claims description 9
- 238000002156 mixing Methods 0.000 claims description 9
- 102000001187 Collagen Type III Human genes 0.000 claims description 8
- 108010069502 Collagen Type III Proteins 0.000 claims description 8
- 239000004005 microsphere Substances 0.000 claims description 8
- 108090000623 proteins and genes Proteins 0.000 claims description 8
- 102000004169 proteins and genes Human genes 0.000 claims description 8
- 238000012377 drug delivery Methods 0.000 claims description 7
- 150000004676 glycans Chemical class 0.000 claims description 7
- 229920001282 polysaccharide Polymers 0.000 claims description 7
- 239000005017 polysaccharide Substances 0.000 claims description 7
- 102000012422 Collagen Type I Human genes 0.000 claims description 6
- 108010022452 Collagen Type I Proteins 0.000 claims description 6
- 150000001875 compounds Chemical class 0.000 claims description 6
- 108090000288 Glycoproteins Proteins 0.000 claims description 5
- 102000003886 Glycoproteins Human genes 0.000 claims description 5
- WOBHKFSMXKNTIM-UHFFFAOYSA-N Hydroxyethyl methacrylate Chemical compound CC(=C)C(=O)OCCO WOBHKFSMXKNTIM-UHFFFAOYSA-N 0.000 claims description 5
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 claims description 4
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 claims description 4
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 claims description 4
- 210000002744 extracellular matrix Anatomy 0.000 claims description 4
- 229920002674 hyaluronan Polymers 0.000 claims description 4
- 229960003160 hyaluronic acid Drugs 0.000 claims description 4
- 108090000790 Enzymes Proteins 0.000 claims description 3
- 102000004190 Enzymes Human genes 0.000 claims description 3
- CERQOIWHTDAKMF-UHFFFAOYSA-N Methacrylic acid Chemical compound CC(=C)C(O)=O CERQOIWHTDAKMF-UHFFFAOYSA-N 0.000 claims description 3
- 230000002378 acidificating effect Effects 0.000 claims description 3
- 239000003443 antiviral agent Substances 0.000 claims description 3
- 230000003013 cytotoxicity Effects 0.000 claims description 3
- 231100000135 cytotoxicity Toxicity 0.000 claims description 3
- 125000004386 diacrylate group Chemical group 0.000 claims description 3
- 238000009434 installation Methods 0.000 claims description 3
- 239000002077 nanosphere Substances 0.000 claims description 3
- 102000000503 Collagen Type II Human genes 0.000 claims description 2
- 108010041390 Collagen Type II Proteins 0.000 claims description 2
- 102000004127 Cytokines Human genes 0.000 claims description 2
- 108090000695 Cytokines Proteins 0.000 claims description 2
- 102000016942 Elastin Human genes 0.000 claims description 2
- 108010014258 Elastin Proteins 0.000 claims description 2
- 108010010803 Gelatin Proteins 0.000 claims description 2
- 229920002683 Glycosaminoglycan Polymers 0.000 claims description 2
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 claims description 2
- 239000002202 Polyethylene glycol Substances 0.000 claims description 2
- 239000003242 anti bacterial agent Substances 0.000 claims description 2
- 239000000427 antigen Substances 0.000 claims description 2
- 102000036639 antigens Human genes 0.000 claims description 2
- 108091007433 antigens Proteins 0.000 claims description 2
- 230000021164 cell adhesion Effects 0.000 claims description 2
- 229920002549 elastin Polymers 0.000 claims description 2
- 229940012952 fibrinogen Drugs 0.000 claims description 2
- 239000012634 fragment Substances 0.000 claims description 2
- 229920000159 gelatin Polymers 0.000 claims description 2
- 235000019322 gelatine Nutrition 0.000 claims description 2
- 235000011852 gelatine desserts Nutrition 0.000 claims description 2
- 239000005556 hormone Substances 0.000 claims description 2
- 229940088597 hormone Drugs 0.000 claims description 2
- 231100001083 no cytotoxicity Toxicity 0.000 claims description 2
- 230000002188 osteogenic effect Effects 0.000 claims description 2
- YHHSONZFOIEMCP-UHFFFAOYSA-O phosphocholine Chemical compound C[N+](C)(C)CCOP(O)(O)=O YHHSONZFOIEMCP-UHFFFAOYSA-O 0.000 claims description 2
- 229950004354 phosphorylcholine Drugs 0.000 claims description 2
- 241000124008 Mammalia Species 0.000 claims 3
- 238000000465 moulding Methods 0.000 claims 2
- 102000004266 Collagen Type IV Human genes 0.000 claims 1
- 108010042086 Collagen Type IV Proteins 0.000 claims 1
- 102000012432 Collagen Type V Human genes 0.000 claims 1
- 108010022514 Collagen Type V Proteins 0.000 claims 1
- 102000002734 Collagen Type VI Human genes 0.000 claims 1
- 108010043741 Collagen Type VI Proteins 0.000 claims 1
- 125000005250 alkyl acrylate group Chemical group 0.000 claims 1
- 239000008273 gelatin Substances 0.000 claims 1
- 230000000379 polymerizing effect Effects 0.000 claims 1
- 150000004492 retinoid derivatives Chemical class 0.000 claims 1
- 239000000243 solution Substances 0.000 description 68
- NQTADLQHYWFPDB-UHFFFAOYSA-N N-Hydroxysuccinimide Chemical compound ON1C(=O)CCC1=O NQTADLQHYWFPDB-UHFFFAOYSA-N 0.000 description 59
- ZSZRUEAFVQITHH-UHFFFAOYSA-N 2-(2-methylprop-2-enoyloxy)ethyl 2-(trimethylazaniumyl)ethyl phosphate Chemical compound CC(=C)C(=O)OCCOP([O-])(=O)OCC[N+](C)(C)C ZSZRUEAFVQITHH-UHFFFAOYSA-N 0.000 description 52
- 239000007987 MES buffer Substances 0.000 description 47
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 36
- 230000003287 optical effect Effects 0.000 description 36
- 239000002953 phosphate buffered saline Substances 0.000 description 36
- ROOXNKNUYICQNP-UHFFFAOYSA-N ammonium persulfate Chemical compound [NH4+].[NH4+].[O-]S(=O)(=O)OOS([O-])(=O)=O ROOXNKNUYICQNP-UHFFFAOYSA-N 0.000 description 30
- 230000005540 biological transmission Effects 0.000 description 30
- 238000000338 in vitro Methods 0.000 description 23
- 210000001519 tissue Anatomy 0.000 description 23
- 239000011159 matrix material Substances 0.000 description 22
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 20
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 18
- 238000012360 testing method Methods 0.000 description 17
- 239000011521 glass Substances 0.000 description 16
- 229910001870 ammonium persulfate Inorganic materials 0.000 description 15
- 230000010261 cell growth Effects 0.000 description 15
- 239000000499 gel Substances 0.000 description 15
- KWYHDKDOAIKMQN-UHFFFAOYSA-N N,N,N',N'-tetramethylethylenediamine Chemical compound CN(C)CCN(C)C KWYHDKDOAIKMQN-UHFFFAOYSA-N 0.000 description 14
- 238000006243 chemical reaction Methods 0.000 description 14
- 239000004971 Cross linker Substances 0.000 description 13
- 229920000671 polyethylene glycol diacrylate Polymers 0.000 description 13
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 12
- 230000000975 bioactive effect Effects 0.000 description 12
- 238000004519 manufacturing process Methods 0.000 description 12
- 102000004196 processed proteins & peptides Human genes 0.000 description 12
- LMDZBCPBFSXMTL-UHFFFAOYSA-N 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide Chemical compound CCN=C=NCCCN(C)C LMDZBCPBFSXMTL-UHFFFAOYSA-N 0.000 description 11
- 241001465754 Metazoa Species 0.000 description 11
- 230000001225 therapeutic effect Effects 0.000 description 11
- 238000001727 in vivo Methods 0.000 description 10
- 238000002347 injection Methods 0.000 description 10
- 239000007924 injection Substances 0.000 description 10
- 230000008929 regeneration Effects 0.000 description 10
- 238000011069 regeneration method Methods 0.000 description 10
- 239000000853 adhesive Substances 0.000 description 8
- 238000003556 assay Methods 0.000 description 8
- 229920003023 plastic Polymers 0.000 description 8
- 239000004033 plastic Substances 0.000 description 8
- 238000002360 preparation method Methods 0.000 description 8
- 238000001356 surgical procedure Methods 0.000 description 8
- 229920006355 Tefzel Polymers 0.000 description 7
- 230000001070 adhesive effect Effects 0.000 description 7
- 238000006065 biodegradation reaction Methods 0.000 description 7
- 210000004204 blood vessel Anatomy 0.000 description 7
- 239000006227 byproduct Substances 0.000 description 7
- 210000002889 endothelial cell Anatomy 0.000 description 7
- 210000002919 epithelial cell Anatomy 0.000 description 7
- 210000000981 epithelium Anatomy 0.000 description 7
- QHSJIZLJUFMIFP-UHFFFAOYSA-N ethene;1,1,2,2-tetrafluoroethene Chemical compound C=C.FC(F)=C(F)F QHSJIZLJUFMIFP-UHFFFAOYSA-N 0.000 description 7
- 239000012456 homogeneous solution Substances 0.000 description 7
- 238000007654 immersion Methods 0.000 description 7
- 230000001965 increasing effect Effects 0.000 description 7
- 238000005086 pumping Methods 0.000 description 7
- 210000000130 stem cell Anatomy 0.000 description 7
- 102000009123 Fibrin Human genes 0.000 description 6
- 108010073385 Fibrin Proteins 0.000 description 6
- BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 description 6
- 241000282898 Sus scrofa Species 0.000 description 6
- 210000004045 bowman membrane Anatomy 0.000 description 6
- 239000003795 chemical substances by application Substances 0.000 description 6
- 229950003499 fibrin Drugs 0.000 description 6
- 239000008240 homogeneous mixture Substances 0.000 description 6
- 239000005457 ice water Substances 0.000 description 6
- 238000010348 incorporation Methods 0.000 description 6
- 230000035699 permeability Effects 0.000 description 6
- 239000000843 powder Substances 0.000 description 6
- 238000010561 standard procedure Methods 0.000 description 6
- 239000000126 substance Substances 0.000 description 6
- SXGZJKUKBWWHRA-UHFFFAOYSA-N 2-(N-morpholiniumyl)ethanesulfonate Chemical compound [O-]S(=O)(=O)CC[NH+]1CCOCC1 SXGZJKUKBWWHRA-UHFFFAOYSA-N 0.000 description 5
- 239000012620 biological material Substances 0.000 description 5
- 230000001851 biosynthetic effect Effects 0.000 description 5
- 229940096422 collagen type i Drugs 0.000 description 5
- 239000003431 cross linking reagent Substances 0.000 description 5
- 239000003292 glue Substances 0.000 description 5
- 235000015097 nutrients Nutrition 0.000 description 5
- 239000007793 ph indicator Substances 0.000 description 5
- 238000011417 postcuring Methods 0.000 description 5
- 230000035945 sensitivity Effects 0.000 description 5
- SQDAZGGFXASXDW-UHFFFAOYSA-N 5-bromo-2-(trifluoromethoxy)pyridine Chemical compound FC(F)(F)OC1=CC=C(Br)C=N1 SQDAZGGFXASXDW-UHFFFAOYSA-N 0.000 description 4
- 102000007547 Laminin Human genes 0.000 description 4
- 108010085895 Laminin Proteins 0.000 description 4
- 241000700159 Rattus Species 0.000 description 4
- 230000033115 angiogenesis Effects 0.000 description 4
- 230000004071 biological effect Effects 0.000 description 4
- 230000003592 biomimetic effect Effects 0.000 description 4
- 230000015556 catabolic process Effects 0.000 description 4
- 229940059329 chondroitin sulfate Drugs 0.000 description 4
- 238000006731 degradation reaction Methods 0.000 description 4
- 230000003511 endothelial effect Effects 0.000 description 4
- 230000002708 enhancing effect Effects 0.000 description 4
- 210000002569 neuron Anatomy 0.000 description 4
- 230000029663 wound healing Effects 0.000 description 4
- 241000894006 Bacteria Species 0.000 description 3
- 208000002177 Cataract Diseases 0.000 description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
- 206010061218 Inflammation Diseases 0.000 description 3
- 241000283973 Oryctolagus cuniculus Species 0.000 description 3
- 230000000844 anti-bacterial effect Effects 0.000 description 3
- 239000007864 aqueous solution Substances 0.000 description 3
- 238000000149 argon plasma sintering Methods 0.000 description 3
- 230000003385 bacteriostatic effect Effects 0.000 description 3
- 150000001718 carbodiimides Chemical class 0.000 description 3
- 229920001577 copolymer Polymers 0.000 description 3
- 238000009792 diffusion process Methods 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 239000008103 glucose Substances 0.000 description 3
- 239000001963 growth medium Substances 0.000 description 3
- 230000036512 infertility Effects 0.000 description 3
- 230000004054 inflammatory process Effects 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- 210000003205 muscle Anatomy 0.000 description 3
- 231100000065 noncytotoxic Toxicity 0.000 description 3
- 230000002020 noncytotoxic effect Effects 0.000 description 3
- 210000000056 organ Anatomy 0.000 description 3
- 230000002980 postoperative effect Effects 0.000 description 3
- 238000010008 shearing Methods 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- 239000013589 supplement Substances 0.000 description 3
- 239000003106 tissue adhesive Substances 0.000 description 3
- 238000002054 transplantation Methods 0.000 description 3
- 108060005980 Collagenase Proteins 0.000 description 2
- 102000029816 Collagenase Human genes 0.000 description 2
- 206010011039 Corneal perforation Diseases 0.000 description 2
- 229920001651 Cyanoacrylate Polymers 0.000 description 2
- 108010054218 Factor VIII Proteins 0.000 description 2
- 102000001690 Factor VIII Human genes 0.000 description 2
- 102000016359 Fibronectins Human genes 0.000 description 2
- 108010067306 Fibronectins Proteins 0.000 description 2
- MWCLLHOVUTZFKS-UHFFFAOYSA-N Methyl cyanoacrylate Chemical compound COC(=O)C(=C)C#N MWCLLHOVUTZFKS-UHFFFAOYSA-N 0.000 description 2
- 206010029113 Neovascularisation Diseases 0.000 description 2
- 108010025020 Nerve Growth Factor Proteins 0.000 description 2
- 208000012868 Overgrowth Diseases 0.000 description 2
- 206010052428 Wound Diseases 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 125000003172 aldehyde group Chemical group 0.000 description 2
- 208000002205 allergic conjunctivitis Diseases 0.000 description 2
- 210000001691 amnion Anatomy 0.000 description 2
- 108010045569 atelocollagen Proteins 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 235000014633 carbohydrates Nutrition 0.000 description 2
- 230000024245 cell differentiation Effects 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 238000012512 characterization method Methods 0.000 description 2
- 210000004978 chinese hamster ovary cell Anatomy 0.000 description 2
- 210000000349 chromosome Anatomy 0.000 description 2
- 239000000512 collagen gel Substances 0.000 description 2
- 229960002424 collagenase Drugs 0.000 description 2
- 238000004624 confocal microscopy Methods 0.000 description 2
- 239000002537 cosmetic Substances 0.000 description 2
- NLCKLZIHJQEMCU-UHFFFAOYSA-N cyano prop-2-enoate Chemical class C=CC(=O)OC#N NLCKLZIHJQEMCU-UHFFFAOYSA-N 0.000 description 2
- 231100000433 cytotoxic Toxicity 0.000 description 2
- 230000001472 cytotoxic effect Effects 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 208000035475 disorder Diseases 0.000 description 2
- 238000004090 dissolution Methods 0.000 description 2
- 238000005538 encapsulation Methods 0.000 description 2
- 229940088598 enzyme Drugs 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 238000010562 histological examination Methods 0.000 description 2
- 210000002865 immune cell Anatomy 0.000 description 2
- 230000002757 inflammatory effect Effects 0.000 description 2
- 239000003112 inhibitor Substances 0.000 description 2
- 230000000302 ischemic effect Effects 0.000 description 2
- 238000011068 loading method Methods 0.000 description 2
- 210000003141 lower extremity Anatomy 0.000 description 2
- 229920002521 macromolecule Polymers 0.000 description 2
- 239000003550 marker Substances 0.000 description 2
- 244000309715 mini pig Species 0.000 description 2
- QNILTEGFHQSKFF-UHFFFAOYSA-N n-propan-2-ylprop-2-enamide Chemical compound CC(C)NC(=O)C=C QNILTEGFHQSKFF-UHFFFAOYSA-N 0.000 description 2
- 230000017074 necrotic cell death Effects 0.000 description 2
- 206010069732 neurotrophic keratopathy Diseases 0.000 description 2
- 238000010899 nucleation Methods 0.000 description 2
- 230000000149 penetrating effect Effects 0.000 description 2
- 238000006116 polymerization reaction Methods 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 230000035755 proliferation Effects 0.000 description 2
- 208000014733 refractive error Diseases 0.000 description 2
- 230000008439 repair process Effects 0.000 description 2
- QGNJRVVDBSJHIZ-QHLGVNSISA-N retinyl acetate Chemical compound CC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C QGNJRVVDBSJHIZ-QHLGVNSISA-N 0.000 description 2
- 238000001878 scanning electron micrograph Methods 0.000 description 2
- 210000003786 sclera Anatomy 0.000 description 2
- 210000002027 skeletal muscle Anatomy 0.000 description 2
- 230000006641 stabilisation Effects 0.000 description 2
- 238000011105 stabilization Methods 0.000 description 2
- 238000007920 subcutaneous administration Methods 0.000 description 2
- 238000013268 sustained release Methods 0.000 description 2
- 239000012730 sustained-release form Substances 0.000 description 2
- 229920002994 synthetic fiber Polymers 0.000 description 2
- 229940075469 tissue adhesives Drugs 0.000 description 2
- 230000017423 tissue regeneration Effects 0.000 description 2
- QDZOEBFLNHCSSF-PFFBOGFISA-N (2S)-2-[[(2R)-2-[[(2S)-1-[(2S)-6-amino-2-[[(2S)-1-[(2R)-2-amino-5-carbamimidamidopentanoyl]pyrrolidine-2-carbonyl]amino]hexanoyl]pyrrolidine-2-carbonyl]amino]-3-(1H-indol-3-yl)propanoyl]amino]-N-[(2R)-1-[[(2S)-1-[[(2R)-1-[[(2S)-1-[[(2S)-1-amino-4-methyl-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]pentanediamide Chemical compound C([C@@H](C(=O)N[C@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(N)=O)NC(=O)[C@@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CCCCN)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](N)CCCNC(N)=N)C1=CC=CC=C1 QDZOEBFLNHCSSF-PFFBOGFISA-N 0.000 description 1
- MWOGMBZGFFZBMK-LJZWMIMPSA-N (2s)-2-[[(2s)-2-[[2-[[(2s,3s)-2-[[(2s)-2-amino-3-(4-hydroxyphenyl)propanoyl]amino]-3-methylpentanoyl]amino]acetyl]amino]-3-hydroxypropanoyl]amino]-5-(diaminomethylideneamino)pentanoic acid Chemical compound NC(N)=NCCC[C@@H](C(O)=O)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 MWOGMBZGFFZBMK-LJZWMIMPSA-N 0.000 description 1
- KUQRLZZWFINMDP-BGNLRFAXSA-N 2-[(3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyethyl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OCCOC1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O KUQRLZZWFINMDP-BGNLRFAXSA-N 0.000 description 1
- DBCAQXHNJOFNGC-UHFFFAOYSA-N 4-bromo-1,1,1-trifluorobutane Chemical compound FC(F)(F)CCCBr DBCAQXHNJOFNGC-UHFFFAOYSA-N 0.000 description 1
- 102000009027 Albumins Human genes 0.000 description 1
- 108010088751 Albumins Proteins 0.000 description 1
- 231100000039 Ames test Toxicity 0.000 description 1
- 102000044503 Antimicrobial Peptides Human genes 0.000 description 1
- 108700042778 Antimicrobial Peptides Proteins 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 108091060290 Chromatid Proteins 0.000 description 1
- 208000031404 Chromosome Aberrations Diseases 0.000 description 1
- 206010010744 Conjunctivitis allergic Diseases 0.000 description 1
- 206010054760 Corneal thinning Diseases 0.000 description 1
- 241000238424 Crustacea Species 0.000 description 1
- 108020004414 DNA Proteins 0.000 description 1
- 102000000541 Defensins Human genes 0.000 description 1
- 108010002069 Defensins Proteins 0.000 description 1
- ZNZYKNKBJPZETN-WELNAUFTSA-N Dialdehyde 11678 Chemical compound N1C2=CC=CC=C2C2=C1[C@H](C[C@H](/C(=C/O)C(=O)OC)[C@@H](C=C)C=O)NCC2 ZNZYKNKBJPZETN-WELNAUFTSA-N 0.000 description 1
- 201000003542 Factor VIII deficiency Diseases 0.000 description 1
- 208000005422 Foreign-Body reaction Diseases 0.000 description 1
- 206010064571 Gene mutation Diseases 0.000 description 1
- 206010018258 Giant papillary conjunctivitis Diseases 0.000 description 1
- 208000010412 Glaucoma Diseases 0.000 description 1
- 241000193159 Hathewaya histolytica Species 0.000 description 1
- 208000031220 Hemophilia Diseases 0.000 description 1
- 208000009292 Hemophilia A Diseases 0.000 description 1
- 206010025323 Lymphomas Diseases 0.000 description 1
- CERQOIWHTDAKMF-UHFFFAOYSA-M Methacrylate Chemical compound CC(=C)C([O-])=O CERQOIWHTDAKMF-UHFFFAOYSA-M 0.000 description 1
- 239000011837 N,N-methylenebisacrylamide Substances 0.000 description 1
- 102000007072 Nerve Growth Factors Human genes 0.000 description 1
- 231100000694 OECD Guidelines for the Testing of Chemicals Toxicity 0.000 description 1
- 102000016611 Proteoglycans Human genes 0.000 description 1
- 108010067787 Proteoglycans Proteins 0.000 description 1
- 241000589516 Pseudomonas Species 0.000 description 1
- 241000283984 Rodentia Species 0.000 description 1
- 241000191940 Staphylococcus Species 0.000 description 1
- 201000005010 Streptococcus pneumonia Diseases 0.000 description 1
- 241000193998 Streptococcus pneumoniae Species 0.000 description 1
- 102400000096 Substance P Human genes 0.000 description 1
- 101800003906 Substance P Proteins 0.000 description 1
- 239000004826 Synthetic adhesive Substances 0.000 description 1
- 102000007000 Tenascin Human genes 0.000 description 1
- 108010008125 Tenascin Proteins 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- SHGAZHPCJJPHSC-YCNIQYBTSA-N all-trans-retinoic acid Chemical compound OC(=O)\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C SHGAZHPCJJPHSC-YCNIQYBTSA-N 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 239000012736 aqueous medium Substances 0.000 description 1
- 201000009310 astigmatism Diseases 0.000 description 1
- 238000004630 atomic force microscopy Methods 0.000 description 1
- 208000024998 atopic conjunctivitis Diseases 0.000 description 1
- 238000001574 biopsy Methods 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000010836 blood and blood product Substances 0.000 description 1
- 229940125691 blood product Drugs 0.000 description 1
- 210000001185 bone marrow Anatomy 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 210000000845 cartilage Anatomy 0.000 description 1
- 108010015046 cell aggregation factors Proteins 0.000 description 1
- 238000013098 chemical test method Methods 0.000 description 1
- 210000004756 chromatid Anatomy 0.000 description 1
- 231100000005 chromosome aberration Toxicity 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 239000008199 coating composition Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 210000000795 conjunctiva Anatomy 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 210000003683 corneal stroma Anatomy 0.000 description 1
- 238000012937 correction Methods 0.000 description 1
- 238000002316 cosmetic surgery Methods 0.000 description 1
- 239000011557 critical solution Substances 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 210000003038 endothelium Anatomy 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 210000003560 epithelium corneal Anatomy 0.000 description 1
- STVZJERGLQHEKB-UHFFFAOYSA-N ethylene glycol dimethacrylate Substances CC(=C)C(=O)OCCOC(=O)C(C)=C STVZJERGLQHEKB-UHFFFAOYSA-N 0.000 description 1
- 238000013266 extended drug release Methods 0.000 description 1
- 238000013265 extended release Methods 0.000 description 1
- 229960000301 factor viii Drugs 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 231100000089 gene mutation induction Toxicity 0.000 description 1
- 238000007429 general method Methods 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- JCYWCSGERIELPG-UHFFFAOYSA-N imes Chemical compound CC1=CC(C)=CC(C)=C1N1C=CN(C=2C(=CC(C)=CC=2C)C)[C]1 JCYWCSGERIELPG-UHFFFAOYSA-N 0.000 description 1
- 238000010166 immunofluorescence Methods 0.000 description 1
- 230000005847 immunogenicity Effects 0.000 description 1
- 238000012309 immunohistochemistry technique Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000008595 infiltration Effects 0.000 description 1
- 238000001764 infiltration Methods 0.000 description 1
- 210000004969 inflammatory cell Anatomy 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 238000013101 initial test Methods 0.000 description 1
- 239000003999 initiator Substances 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 230000030214 innervation Effects 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 206010023332 keratitis Diseases 0.000 description 1
- 230000033001 locomotion Effects 0.000 description 1
- 210000004962 mammalian cell Anatomy 0.000 description 1
- 238000007726 management method Methods 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 230000005012 migration Effects 0.000 description 1
- 238000013508 migration Methods 0.000 description 1
- 230000000394 mitotic effect Effects 0.000 description 1
- 150000002772 monosaccharides Chemical class 0.000 description 1
- 231100000243 mutagenic effect Toxicity 0.000 description 1
- 230000003505 mutagenic effect Effects 0.000 description 1
- ZIUHHBKFKCYYJD-UHFFFAOYSA-N n,n'-methylenebisacrylamide Chemical compound C=CC(=O)NCNC(=O)C=C ZIUHHBKFKCYYJD-UHFFFAOYSA-N 0.000 description 1
- 229940088644 n,n-dimethylacrylamide Drugs 0.000 description 1
- YLGYACDQVQQZSW-UHFFFAOYSA-N n,n-dimethylprop-2-enamide Chemical compound CN(C)C(=O)C=C YLGYACDQVQQZSW-UHFFFAOYSA-N 0.000 description 1
- 229920005615 natural polymer Polymers 0.000 description 1
- 230000008035 nerve activity Effects 0.000 description 1
- 230000001537 neural effect Effects 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 150000002482 oligosaccharides Chemical class 0.000 description 1
- 238000005580 one pot reaction Methods 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 238000003359 percent control normalization Methods 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 239000012466 permeate Substances 0.000 description 1
- 238000005191 phase separation Methods 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 238000013031 physical testing Methods 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 238000013310 pig model Methods 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000000069 prophylactic effect Effects 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 239000000376 reactant Substances 0.000 description 1
- 230000008707 rearrangement Effects 0.000 description 1
- 230000007115 recruitment Effects 0.000 description 1
- 230000001172 regenerating effect Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 229930002330 retinoic acid Natural products 0.000 description 1
- 229960000342 retinol acetate Drugs 0.000 description 1
- 235000019173 retinyl acetate Nutrition 0.000 description 1
- 239000011770 retinyl acetate Substances 0.000 description 1
- 238000011808 rodent model Methods 0.000 description 1
- 239000012047 saturated solution Substances 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- 239000000565 sealant Substances 0.000 description 1
- CSMWJXBSXGUPGY-UHFFFAOYSA-L sodium dithionate Chemical compound [Na+].[Na+].[O-]S(=O)(=O)S([O-])(=O)=O CSMWJXBSXGUPGY-UHFFFAOYSA-L 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 210000003594 spinal ganglia Anatomy 0.000 description 1
- 238000012289 standard assay Methods 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 239000002352 surface water Substances 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000009897 systematic effect Effects 0.000 description 1
- 229960003766 thrombin (human) Drugs 0.000 description 1
- 230000014599 transmission of virus Effects 0.000 description 1
- 230000000472 traumatic effect Effects 0.000 description 1
- 230000008736 traumatic injury Effects 0.000 description 1
- 229960001727 tretinoin Drugs 0.000 description 1
- 108010052768 tyrosyl-isoleucyl-glycyl-seryl-arginine Proteins 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 239000003981 vehicle Substances 0.000 description 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L101/00—Compositions of unspecified macromolecular compounds
- C08L101/12—Compositions of unspecified macromolecular compounds characterised by physical features, e.g. anisotropy, viscosity or electrical conductivity
- C08L101/14—Compositions of unspecified macromolecular compounds characterised by physical features, e.g. anisotropy, viscosity or electrical conductivity the macromolecular compounds being water soluble or water swellable, e.g. aqueous gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/52—Hydrogels or hydrocolloids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
- A61K9/0051—Ocular inserts, ocular implants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08F283/00—Macromolecular compounds obtained by polymerising monomers on to polymers provided for in subclass C08G
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08F283/00—Macromolecular compounds obtained by polymerising monomers on to polymers provided for in subclass C08G
- C08F283/06—Macromolecular compounds obtained by polymerising monomers on to polymers provided for in subclass C08G on to polyethers, polyoxymethylenes or polyacetals
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08H—DERIVATIVES OF NATURAL MACROMOLECULAR COMPOUNDS
- C08H1/00—Macromolecular products derived from proteins
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J3/00—Processes of treating or compounding macromolecular substances
- C08J3/24—Crosslinking, e.g. vulcanising, of macromolecules
- C08J3/246—Intercrosslinking of at least two polymers
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L33/00—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides or nitriles thereof; Compositions of derivatives of such polymers
- C08L33/04—Homopolymers or copolymers of esters
- C08L33/14—Homopolymers or copolymers of esters of esters containing halogen, nitrogen, sulfur, or oxygen atoms in addition to the carboxy oxygen
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L5/00—Compositions of polysaccharides or of their derivatives not provided for in groups C08L1/00 or C08L3/00
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L5/00—Compositions of polysaccharides or of their derivatives not provided for in groups C08L1/00 or C08L3/00
- C08L5/04—Alginic acid; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L5/00—Compositions of polysaccharides or of their derivatives not provided for in groups C08L1/00 or C08L3/00
- C08L5/08—Chitin; Chondroitin sulfate; Hyaluronic acid; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L89/00—Compositions of proteins; Compositions of derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L89/00—Compositions of proteins; Compositions of derivatives thereof
- C08L89/04—Products derived from waste materials, e.g. horn, hoof or hair
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L89/00—Compositions of proteins; Compositions of derivatives thereof
- C08L89/04—Products derived from waste materials, e.g. horn, hoof or hair
- C08L89/06—Products derived from waste materials, e.g. horn, hoof or hair derived from leather or skin, e.g. gelatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J2300/00—Characterised by the use of unspecified polymers
- C08J2300/16—Biodegradable polymers
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L2205/00—Polymer mixtures characterised by other features
- C08L2205/04—Polymer mixtures characterised by other features containing interpenetrating networks
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Polymers & Plastics (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Dermatology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Transplantation (AREA)
- Dispersion Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Ophthalmology & Optometry (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Materials Engineering (AREA)
- Inorganic Chemistry (AREA)
- Materials For Medical Uses (AREA)
- Compositions Of Macromolecular Compounds (AREA)
- Prostheses (AREA)
- Processes Of Treating Macromolecular Substances (AREA)
- Graft Or Block Polymers (AREA)
- Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US71541105P | 2005-09-09 | 2005-09-09 | |
| US60/715,411 | 2005-09-09 | ||
| PCT/CA2006/001520 WO2007028258A2 (en) | 2005-09-09 | 2006-09-11 | Interpenetrating networks, and related methods and compositions |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CA2621824A1 CA2621824A1 (en) | 2007-03-15 |
| CA2621824C true CA2621824C (en) | 2014-10-07 |
Family
ID=37836182
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA2621824A Expired - Fee Related CA2621824C (en) | 2005-09-09 | 2006-09-11 | Interpenetrating networks, and related methods and compositions |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20080317818A1 (enExample) |
| EP (2) | EP1934289A4 (enExample) |
| JP (2) | JP2009507110A (enExample) |
| KR (1) | KR101382083B1 (enExample) |
| CN (1) | CN101305052B (enExample) |
| AU (1) | AU2006289625B2 (enExample) |
| CA (1) | CA2621824C (enExample) |
| SG (2) | SG10201807556TA (enExample) |
| WO (1) | WO2007028258A2 (enExample) |
Families Citing this family (193)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6302875B1 (en) | 1996-10-11 | 2001-10-16 | Transvascular, Inc. | Catheters and related devices for forming passageways between blood vessels or other anatomical structures |
| US8150519B2 (en) | 2002-04-08 | 2012-04-03 | Ardian, Inc. | Methods and apparatus for bilateral renal neuromodulation |
| US20070129761A1 (en) | 2002-04-08 | 2007-06-07 | Ardian, Inc. | Methods for treating heart arrhythmia |
| US7617005B2 (en) | 2002-04-08 | 2009-11-10 | Ardian, Inc. | Methods and apparatus for thermally-induced renal neuromodulation |
| US20070135875A1 (en) | 2002-04-08 | 2007-06-14 | Ardian, Inc. | Methods and apparatus for thermally-induced renal neuromodulation |
| US9636174B2 (en) | 2002-04-08 | 2017-05-02 | Medtronic Ardian Luxembourg S.A.R.L. | Methods for therapeutic renal neuromodulation |
| US20080213331A1 (en) | 2002-04-08 | 2008-09-04 | Ardian, Inc. | Methods and devices for renal nerve blocking |
| JP2006508709A (ja) | 2002-09-13 | 2006-03-16 | オキュラー サイエンシス インコーポレイテッド | 視力を向上させる器具及び方法 |
| ES2564694T3 (es) | 2003-09-12 | 2016-03-28 | Vessix Vascular, Inc. | Sistema de remodelación y / o ablación excéntrica seleccionable de material ateroesclerótico |
| CA2566961A1 (en) | 2004-05-20 | 2005-12-08 | Coopervision, Inc. | Corneal onlays and wavefront aberration correction to enhance vision |
| US9713730B2 (en) | 2004-09-10 | 2017-07-25 | Boston Scientific Scimed, Inc. | Apparatus and method for treatment of in-stent restenosis |
| US8396548B2 (en) | 2008-11-14 | 2013-03-12 | Vessix Vascular, Inc. | Selective drug delivery in a lumen |
| US7909867B2 (en) * | 2004-10-05 | 2011-03-22 | The Board Of Trustees Of The Leland Stanford Junior University | Interpenetrating polymer network hydrogel corneal prosthesis |
| US20090088846A1 (en) | 2007-04-17 | 2009-04-02 | David Myung | Hydrogel arthroplasty device |
| US7857849B2 (en) * | 2004-10-05 | 2010-12-28 | The Board Of Trustees Of The Leland Stanford Junior Iniversity | Artificial corneal implant |
| US7857447B2 (en) * | 2004-10-05 | 2010-12-28 | The Board Of Trustees Of The Leland Stanford Junior University | Interpenetrating polymer network hydrogel contact lenses |
| WO2006063199A2 (en) | 2004-12-09 | 2006-06-15 | The Foundry, Inc. | Aortic valve repair |
| US8019435B2 (en) | 2006-05-02 | 2011-09-13 | Boston Scientific Scimed, Inc. | Control of arterial smooth muscle tone |
| US20080089923A1 (en) | 2006-09-29 | 2008-04-17 | Burkstrand Michael J | Biodegradable ocular implants and methods for treating ocular conditions |
| WO2008049087A2 (en) | 2006-10-18 | 2008-04-24 | Minnow Medical, Inc. | System for inducing desirable temperature effects on body tissue |
| ES2560006T3 (es) | 2006-10-18 | 2016-02-17 | Vessix Vascular, Inc. | Inducción de efectos de temperatura deseables sobre tejido corporal |
| EP2076193A4 (en) | 2006-10-18 | 2010-02-03 | Minnow Medical Inc | MATCHED RF-ENERGY AND ELECTRO-TISSUE CHARACTERIZATION FOR THE SELECTIVE TREATMENT OF TARGET TISSUE |
| CA2705369C (fr) * | 2007-11-14 | 2016-10-18 | Ma.I.A Woundcare | Biomateriau permettant la delivrance controlee d'actifs |
| FR2924615B1 (fr) * | 2007-12-07 | 2010-01-22 | Vivacy Lab | Hydrogel cohesif biodegradable. |
| US20090182068A1 (en) * | 2008-01-14 | 2009-07-16 | Yuwen Liu | Polymerizable Contact Lens Formulations and Contact Lenses Obtained Therefrom |
| US20120209396A1 (en) | 2008-07-07 | 2012-08-16 | David Myung | Orthopedic implants having gradient polymer alloys |
| JP5722773B2 (ja) | 2008-08-05 | 2015-05-27 | バイオミメディカ インコーポレイテッド | ポリウレタングラフト化ヒドロゲル |
| JP5271632B2 (ja) * | 2008-08-08 | 2013-08-21 | 国立大学法人金沢大学 | 神経細胞死抑制作用をもつｖｉ型コラーゲン |
| KR20110104504A (ko) | 2008-11-17 | 2011-09-22 | 미노우 메디컬, 인코포레이티드 | 조직 토폴로지의 지식 여하에 따른 에너지의 선택적 축적 |
| FR2938544B1 (fr) * | 2008-11-20 | 2011-01-21 | Univ Cergy Pontoise | Materiaux sous forme de reseaux interpenetres de polymeres associant un gel de fibrine et un reseau de polyethylene glycol |
| KR100994747B1 (ko) * | 2008-12-31 | 2010-12-07 | 주식회사 인터로조 | 습윤성이 향상된 하이드로젤 콘택트렌즈 |
| EP2398577A2 (en) * | 2009-02-19 | 2011-12-28 | Bonner, Alex Garfield | Porous interpenetrating polymer network |
| US20130085571A1 (en) * | 2009-05-14 | 2013-04-04 | Anja Mueller | Composition and method of preparation of polysaccharide gel-based artificial, biodegradable skin scaffolds |
| WO2011005974A2 (en) * | 2009-07-08 | 2011-01-13 | Northwestern University | Interpenetrating biomaterial matrices and uses thereof |
| EP2481399B1 (en) * | 2009-08-18 | 2015-11-25 | Tohoku University | Sustained drug delivery system |
| US9987225B2 (en) | 2009-09-30 | 2018-06-05 | Ottawa Hospital Research Institute | Crosslinked hydrogels and related method of preparation |
| CN103068330B (zh) | 2010-04-09 | 2016-06-29 | Vessix血管股份有限公司 | 用于治疗组织的功率发生和控制装置 |
| US9192790B2 (en) | 2010-04-14 | 2015-11-24 | Boston Scientific Scimed, Inc. | Focused ultrasonic renal denervation |
| US8473067B2 (en) | 2010-06-11 | 2013-06-25 | Boston Scientific Scimed, Inc. | Renal denervation and stimulation employing wireless vascular energy transfer arrangement |
| CN101891946B (zh) * | 2010-07-17 | 2012-07-04 | 厦门大学 | 一种具有dn-l结构的增强生物水凝胶及其制备方法 |
| US9408661B2 (en) | 2010-07-30 | 2016-08-09 | Patrick A. Haverkost | RF electrodes on multiple flexible wires for renal nerve ablation |
| US9358365B2 (en) | 2010-07-30 | 2016-06-07 | Boston Scientific Scimed, Inc. | Precision electrode movement control for renal nerve ablation |
| US9084609B2 (en) | 2010-07-30 | 2015-07-21 | Boston Scientific Scime, Inc. | Spiral balloon catheter for renal nerve ablation |
| US9463062B2 (en) | 2010-07-30 | 2016-10-11 | Boston Scientific Scimed, Inc. | Cooled conductive balloon RF catheter for renal nerve ablation |
| US9155589B2 (en) | 2010-07-30 | 2015-10-13 | Boston Scientific Scimed, Inc. | Sequential activation RF electrode set for renal nerve ablation |
| WO2012027678A1 (en) | 2010-08-27 | 2012-03-01 | Biomimedica, Inc. | Hydrophobic and hydrophilic interpenetrating polymer networks derived from hydrophobic polymers and methods of preparing the same |
| CN101942198B (zh) * | 2010-09-03 | 2012-05-23 | 东华大学 | 多孔硅水凝胶互穿网络（ipn）膜的制备方法 |
| EP2622594B1 (en) | 2010-10-01 | 2018-08-22 | Applied Medical Resources Corporation | Portable laparoscopic trainer |
| US8974451B2 (en) | 2010-10-25 | 2015-03-10 | Boston Scientific Scimed, Inc. | Renal nerve ablation using conductive fluid jet and RF energy |
| US9220558B2 (en) | 2010-10-27 | 2015-12-29 | Boston Scientific Scimed, Inc. | RF renal denervation catheter with multiple independent electrodes |
| US9028485B2 (en) | 2010-11-15 | 2015-05-12 | Boston Scientific Scimed, Inc. | Self-expanding cooling electrode for renal nerve ablation |
| US9668811B2 (en) | 2010-11-16 | 2017-06-06 | Boston Scientific Scimed, Inc. | Minimally invasive access for renal nerve ablation |
| US9089350B2 (en) | 2010-11-16 | 2015-07-28 | Boston Scientific Scimed, Inc. | Renal denervation catheter with RF electrode and integral contrast dye injection arrangement |
| US9326751B2 (en) | 2010-11-17 | 2016-05-03 | Boston Scientific Scimed, Inc. | Catheter guidance of external energy for renal denervation |
| US9060761B2 (en) | 2010-11-18 | 2015-06-23 | Boston Scientific Scime, Inc. | Catheter-focused magnetic field induced renal nerve ablation |
| US9023034B2 (en) | 2010-11-22 | 2015-05-05 | Boston Scientific Scimed, Inc. | Renal ablation electrode with force-activatable conduction apparatus |
| US9192435B2 (en) | 2010-11-22 | 2015-11-24 | Boston Scientific Scimed, Inc. | Renal denervation catheter with cooled RF electrode |
| US20120157993A1 (en) | 2010-12-15 | 2012-06-21 | Jenson Mark L | Bipolar Off-Wall Electrode Device for Renal Nerve Ablation |
| WO2012100095A1 (en) | 2011-01-19 | 2012-07-26 | Boston Scientific Scimed, Inc. | Guide-compatible large-electrode catheter for renal nerve ablation with reduced arterial injury |
| KR101240133B1 (ko) | 2011-01-27 | 2013-03-11 | 서울대학교산학협력단 | 히알루론산과 알지네이트를 포함하는 상호관입고분자망목 구조의 세포전달용 지지체의 제조방법 |
| US8871016B2 (en) | 2011-08-03 | 2014-10-28 | The Johns Hopkins University | Cellulose-based hydrogels and methods of making thereof |
| US9175153B2 (en) | 2011-03-08 | 2015-11-03 | The Johns Hopkins University | Cellulose hydrogel compositions and contact lenses for corneal applications |
| US9211256B2 (en) | 2011-03-08 | 2015-12-15 | The Johns Hopkins University | Wound healing compositions comprising biocompatible cellulose hydrogel membranes and methods of use thereof |
| EP2694150A1 (en) | 2011-04-08 | 2014-02-12 | Covidien LP | Iontophoresis drug delivery system and method for denervation of the renal sympathetic nerve and iontophoretic drug delivery |
| CN102229732B (zh) * | 2011-05-11 | 2013-04-03 | 东华大学 | 基于半互穿网络结构的pH刺激响应性纳米水凝胶的制备 |
| WO2013013156A2 (en) | 2011-07-20 | 2013-01-24 | Boston Scientific Scimed, Inc. | Percutaneous devices and methods to visualize, target and ablate nerves |
| EP2734264B1 (en) | 2011-07-22 | 2018-11-21 | Boston Scientific Scimed, Inc. | Nerve modulation system with a nerve modulation element positionable in a helical guide |
| WO2013040559A1 (en) * | 2011-09-16 | 2013-03-21 | Wake Forest University Health Sciences | Fabrication of gelatin hydrogel sheet for the transplantation of corneal endothelium |
| KR20140115294A (ko) | 2011-10-03 | 2014-09-30 | 바이오미메디카, 인코포레이티드 | 순응성 재료들을 또 다른 표면으로 앵커링하기 위한 중합체성 접착제 |
| WO2013055826A1 (en) | 2011-10-10 | 2013-04-18 | Boston Scientific Scimed, Inc. | Medical devices including ablation electrodes |
| EP2765940B1 (en) | 2011-10-11 | 2015-08-26 | Boston Scientific Scimed, Inc. | Off-wall electrode device for nerve modulation |
| US9420955B2 (en) | 2011-10-11 | 2016-08-23 | Boston Scientific Scimed, Inc. | Intravascular temperature monitoring system and method |
| US9364284B2 (en) | 2011-10-12 | 2016-06-14 | Boston Scientific Scimed, Inc. | Method of making an off-wall spacer cage |
| EP2768563B1 (en) | 2011-10-18 | 2016-11-09 | Boston Scientific Scimed, Inc. | Deflectable medical devices |
| EP2768568B1 (en) | 2011-10-18 | 2020-05-06 | Boston Scientific Scimed, Inc. | Integrated crossing balloon catheter |
| AU2012325987B2 (en) | 2011-10-21 | 2017-02-02 | Applied Medical Resources Corporation | Simulated tissue structure for surgical training |
| US8951251B2 (en) | 2011-11-08 | 2015-02-10 | Boston Scientific Scimed, Inc. | Ostial renal nerve ablation |
| US9119600B2 (en) | 2011-11-15 | 2015-09-01 | Boston Scientific Scimed, Inc. | Device and methods for renal nerve modulation monitoring |
| EP3335673B1 (en) | 2011-11-21 | 2025-07-30 | Hyalex Orthopaedics, Inc. | Systems for anchoring orthopaedic implants to bone |
| US9119632B2 (en) | 2011-11-21 | 2015-09-01 | Boston Scientific Scimed, Inc. | Deflectable renal nerve ablation catheter |
| CA2859967A1 (en) | 2011-12-20 | 2013-06-27 | Applied Medical Resources Corporation | Advanced surgical simulation |
| CN102532566B (zh) * | 2011-12-21 | 2013-09-25 | 四川大学 | 互穿网络复合水凝胶的制备方法 |
| US9265969B2 (en) | 2011-12-21 | 2016-02-23 | Cardiac Pacemakers, Inc. | Methods for modulating cell function |
| AU2012358143B2 (en) | 2011-12-23 | 2015-06-11 | Boston Scientific Scimed, Inc. | Expandable balloon or an electrode pad with a heat sensing device |
| EP2797534A1 (en) | 2011-12-28 | 2014-11-05 | Boston Scientific Scimed, Inc. | Device and methods for nerve modulation using a novel ablation catheter with polymeric ablative elements |
| JP5939796B2 (ja) * | 2011-12-28 | 2016-06-22 | 学校法人 関西大学 | キチンまたはキトサンと合成高分子との複合体およびその製造方法 |
| US9050106B2 (en) | 2011-12-29 | 2015-06-09 | Boston Scientific Scimed, Inc. | Off-wall electrode device and methods for nerve modulation |
| US9387276B2 (en) | 2012-01-05 | 2016-07-12 | President And Fellows Of Harvard College | Interpenetrating networks with covalent and Ionic Crosslinks |
| CN102688525B (zh) * | 2012-05-07 | 2013-11-27 | 东南大学 | 一种生物大分子水凝胶及其制备方法 |
| WO2013169927A1 (en) | 2012-05-08 | 2013-11-14 | Boston Scientific Scimed, Inc. | Renal nerve modulation devices |
| CN102631711B (zh) * | 2012-05-16 | 2014-03-26 | 金陵科技学院 | 一种水凝胶角膜接触镜药物载体 |
| CN104540465A (zh) | 2012-08-24 | 2015-04-22 | 波士顿科学西美德公司 | 带有含单独微孔隙区域的球囊的血管内导管 |
| US9173696B2 (en) | 2012-09-17 | 2015-11-03 | Boston Scientific Scimed, Inc. | Self-positioning electrode system and method for renal nerve modulation |
| WO2014047411A1 (en) | 2012-09-21 | 2014-03-27 | Boston Scientific Scimed, Inc. | System for nerve modulation and innocuous thermal gradient nerve block |
| US10549127B2 (en) | 2012-09-21 | 2020-02-04 | Boston Scientific Scimed, Inc. | Self-cooling ultrasound ablation catheter |
| CA2885433C (en) | 2012-09-26 | 2023-04-04 | Applied Medical Resources Corporation | Surgical training model for laparoscopic procedures |
| JP6245531B2 (ja) | 2012-09-27 | 2017-12-13 | アプライド メディカル リソーシーズ コーポレイション | 腹腔鏡下手技用の外科用訓練モデル |
| US10679520B2 (en) | 2012-09-27 | 2020-06-09 | Applied Medical Resources Corporation | Surgical training model for laparoscopic procedures |
| EP2906135A2 (en) | 2012-10-10 | 2015-08-19 | Boston Scientific Scimed, Inc. | Renal nerve modulation devices and methods |
| CN102895699A (zh) * | 2012-11-19 | 2013-01-30 | 江南大学 | 一种用于皮肤创伤修复的复合水凝胶敷料的制备方法 |
| EP3660816B1 (en) | 2013-03-01 | 2021-10-13 | Applied Medical Resources Corporation | Advanced surgical simulation constructions and methods |
| WO2014143571A1 (en) | 2013-03-11 | 2014-09-18 | Boston Scientific Scimed, Inc. | Medical devices for modulating nerves |
| US9956033B2 (en) | 2013-03-11 | 2018-05-01 | Boston Scientific Scimed, Inc. | Medical devices for modulating nerves |
| CN103131054B (zh) * | 2013-03-12 | 2015-05-13 | 武汉大学 | 一种高强度水凝胶 |
| US9808311B2 (en) | 2013-03-13 | 2017-11-07 | Boston Scientific Scimed, Inc. | Deflectable medical devices |
| WO2014149690A2 (en) | 2013-03-15 | 2014-09-25 | Boston Scientific Scimed, Inc. | Medical devices and methods for treatment of hypertension that utilize impedance compensation |
| US9827039B2 (en) | 2013-03-15 | 2017-11-28 | Boston Scientific Scimed, Inc. | Methods and apparatuses for remodeling tissue of or adjacent to a body passage |
| US10265122B2 (en) | 2013-03-15 | 2019-04-23 | Boston Scientific Scimed, Inc. | Nerve ablation devices and related methods of use |
| US10336896B2 (en) * | 2013-04-25 | 2019-07-02 | The University Of Akron | One-pot synthesis of highly mechanical and recoverable double-network hydrogels |
| CN103272268B (zh) * | 2013-05-16 | 2015-04-22 | 华南理工大学 | 一种抗菌角膜修复材料及其制备方法 |
| EP3011550B1 (en) | 2013-06-18 | 2018-01-03 | Applied Medical Resources Corporation | Gallbladder model |
| US9943365B2 (en) | 2013-06-21 | 2018-04-17 | Boston Scientific Scimed, Inc. | Renal denervation balloon catheter with ride along electrode support |
| WO2014205399A1 (en) | 2013-06-21 | 2014-12-24 | Boston Scientific Scimed, Inc. | Medical devices for renal nerve ablation having rotatable shafts |
| US9707036B2 (en) | 2013-06-25 | 2017-07-18 | Boston Scientific Scimed, Inc. | Devices and methods for nerve modulation using localized indifferent electrodes |
| AU2014284558B2 (en) | 2013-07-01 | 2017-08-17 | Boston Scientific Scimed, Inc. | Medical devices for renal nerve ablation |
| US10413357B2 (en) | 2013-07-11 | 2019-09-17 | Boston Scientific Scimed, Inc. | Medical device with stretchable electrode assemblies |
| US10660698B2 (en) | 2013-07-11 | 2020-05-26 | Boston Scientific Scimed, Inc. | Devices and methods for nerve modulation |
| WO2015010074A1 (en) | 2013-07-19 | 2015-01-22 | Boston Scientific Scimed, Inc. | Spiral bipolar electrode renal denervation balloon |
| EP3024405A1 (en) | 2013-07-22 | 2016-06-01 | Boston Scientific Scimed, Inc. | Renal nerve ablation catheter having twist balloon |
| EP3024406B1 (en) | 2013-07-22 | 2019-06-19 | Boston Scientific Scimed, Inc. | Medical devices for renal nerve ablation |
| US10198966B2 (en) | 2013-07-24 | 2019-02-05 | Applied Medical Resources Corporation | Advanced first entry model for surgical simulation |
| JP6517201B2 (ja) | 2013-07-24 | 2019-05-22 | アプライド メディカル リソーシーズ コーポレイション | ファーストエントリーモデル |
| JP6159888B2 (ja) | 2013-08-22 | 2017-07-05 | ボストン サイエンティフィック サイムド，インコーポレイテッドＢｏｓｔｏｎ Ｓｃｉｅｎｔｉｆｉｃ Ｓｃｉｍｅｄ，Ｉｎｃ． | 腎神経変調バルーンへの接着性を向上させたフレキシブル回路 |
| US9895194B2 (en) | 2013-09-04 | 2018-02-20 | Boston Scientific Scimed, Inc. | Radio frequency (RF) balloon catheter having flushing and cooling capability |
| EP3043835B1 (en) * | 2013-09-09 | 2020-08-12 | UAB Ferentis | Transparent hydrogel and method of making the same from functionalized natural polymers |
| EP3043733A1 (en) | 2013-09-13 | 2016-07-20 | Boston Scientific Scimed, Inc. | Ablation balloon with vapor deposited cover layer |
| EP3057624B1 (en) | 2013-10-14 | 2018-01-31 | UAB Ferentis | Regenerative prostheses as alternatives to donor corneas for transplantation |
| US11246654B2 (en) | 2013-10-14 | 2022-02-15 | Boston Scientific Scimed, Inc. | Flexible renal nerve ablation devices and related methods of use and manufacture |
| US9687166B2 (en) | 2013-10-14 | 2017-06-27 | Boston Scientific Scimed, Inc. | High resolution cardiac mapping electrode array catheter |
| US9770606B2 (en) | 2013-10-15 | 2017-09-26 | Boston Scientific Scimed, Inc. | Ultrasound ablation catheter with cooling infusion and centering basket |
| WO2015057584A1 (en) | 2013-10-15 | 2015-04-23 | Boston Scientific Scimed, Inc. | Medical device balloon |
| EP3057521B1 (en) | 2013-10-18 | 2020-03-25 | Boston Scientific Scimed, Inc. | Balloon catheters with flexible conducting wires |
| JP2016534842A (ja) | 2013-10-25 | 2016-11-10 | ボストン サイエンティフィック サイムド，インコーポレイテッドＢｏｓｔｏｎ Ｓｃｉｅｎｔｉｆｉｃ Ｓｃｉｍｅｄ，Ｉｎｃ． | 除神経フレックス回路における埋め込み熱電対 |
| JP2016539226A (ja) | 2013-11-20 | 2016-12-15 | トラスティーズ オブ ボストン ユニバーシティ | 注射可能な組織補充物 |
| KR101664444B1 (ko) * | 2013-12-13 | 2016-10-12 | 재단법인 유타 인하 디디에스 및 신의료기술개발 공동연구소 | 생분해성 의료용 접착제 또는 실란트 조성물 |
| CN103655002A (zh) * | 2013-12-13 | 2014-03-26 | 无锡合众信息科技有限公司 | 一种水凝胶人工晶体及其制备方法 |
| US9512279B2 (en) * | 2013-12-18 | 2016-12-06 | Universite Cegy-Pontoise | Interpenetrating polymer network |
| CN105899157B (zh) | 2014-01-06 | 2019-08-09 | 波士顿科学国际有限公司 | 抗撕裂柔性电路组件 |
| US9907609B2 (en) | 2014-02-04 | 2018-03-06 | Boston Scientific Scimed, Inc. | Alternative placement of thermal sensors on bipolar electrode |
| US11000679B2 (en) | 2014-02-04 | 2021-05-11 | Boston Scientific Scimed, Inc. | Balloon protection and rewrapping devices and related methods of use |
| KR102438168B1 (ko) | 2014-03-26 | 2022-08-31 | 어플라이드 메디컬 리소시스 코포레이션 | 시뮬레이션된 절개가능 조직 |
| KR102718882B1 (ko) | 2014-11-13 | 2024-10-17 | 어플라이드 메디컬 리소시스 코포레이션 | 시뮬레이션된 조직 모델들 및 방법들 |
| WO2016100355A1 (en) * | 2014-12-15 | 2016-06-23 | The Regents Of The University Of Colorado, A Body Corporate | Biocompatible hydrogels, systems including the hydrogels, and methods of using and forming same |
| EP4620662A2 (en) | 2015-02-19 | 2025-09-24 | Applied Medical Resources Corporation | Simulated tissue structures and methods |
| EP3253315B1 (en) | 2015-05-14 | 2019-01-02 | Applied Medical Resources Corporation | Synthetic tissue structures for electrosurgical training and simulation |
| EP4057260A1 (en) | 2015-06-09 | 2022-09-14 | Applied Medical Resources Corporation | Hysterectomy model |
| JP7009355B2 (ja) | 2015-07-16 | 2022-01-25 | アプライド メディカル リソーシーズ コーポレイション | 模擬切開可能組織 |
| KR102646090B1 (ko) | 2015-07-22 | 2024-03-12 | 어플라이드 메디컬 리소시스 코포레이션 | 충수절제술 모델 |
| US11077228B2 (en) | 2015-08-10 | 2021-08-03 | Hyalex Orthopaedics, Inc. | Interpenetrating polymer networks |
| KR102649261B1 (ko) | 2015-10-02 | 2024-03-20 | 어플라이드 메디컬 리소시스 코포레이션 | 자궁 절제술 모델 |
| ES2955662T3 (es) | 2015-11-20 | 2023-12-05 | Applied Med Resources | Tejido diseccionable simulado |
| WO2017165490A1 (en) * | 2016-03-22 | 2017-09-28 | President And Fellows Of Harvard College | Biocompatible adhesives and methods of use thereof |
| CN105833344B (zh) * | 2016-04-26 | 2019-04-26 | 青岛慧生惠众生物科技有限公司 | 一种可注射水凝胶在制备眼内填充物中的应用 |
| CN106243600B (zh) * | 2016-06-03 | 2017-10-24 | 深圳市前海金卓生物技术有限公司 | 一种用于油水分离的基质 |
| KR102405187B1 (ko) | 2016-06-27 | 2022-06-07 | 어플라이드 메디컬 리소시스 코포레이션 | 시뮬레이션된 복벽 |
| CN113456889B (zh) * | 2016-07-27 | 2022-06-28 | 珐博进(中国)医药技术开发有限公司 | 生物合成角膜 |
| EP3291208B1 (en) * | 2016-08-31 | 2020-09-30 | Ricoh Company, Ltd. | Hydrogel structure, blood vessel, internal organ model, practice tool for medical procedure, and method of manufacturing the hydrogel structure |
| CN110494156B (zh) | 2016-10-13 | 2022-11-22 | 熹微(苏州)生物医药科技有限公司 | 基于胶原和胶原样肽的水凝胶、角膜植入物、填料胶及其用途 |
| WO2018144966A1 (en) * | 2017-02-06 | 2018-08-09 | The Board Of Trustees Of The Leland Stanford Junior University | Bioconjugation methods for targeted in situ therapeutic delivery |
| ES3004046T3 (en) | 2017-02-14 | 2025-03-11 | Applied Med Resources | Laparoscopic training system |
| US10847057B2 (en) | 2017-02-23 | 2020-11-24 | Applied Medical Resources Corporation | Synthetic tissue structures for electrosurgical training and simulation |
| BR112020001516A2 (pt) * | 2017-07-27 | 2020-07-21 | University Health Network | polímero condutivo à base de ácido benzoico que contém biomaterial para melhoria da condução de tecidos in vitro e in vivo |
| CN107469139B (zh) * | 2017-07-31 | 2021-01-22 | 河南工程学院 | 一种兼具有抗菌和消炎效果的高强度创伤敷料的制备方法 |
| KR101944008B1 (ko) * | 2017-09-18 | 2019-01-30 | (주) 제이씨바이오 | 히알루론산을 포함하는 투명 하이드로겔 막 및 이를 이용한 콘택트렌즈 |
| CN108144109A (zh) * | 2017-12-28 | 2018-06-12 | 浙江海创医疗器械有限公司 | 一种含蜂蜜的互穿网络交联结构的水凝胶敷料 |
| US12168082B2 (en) * | 2017-12-29 | 2024-12-17 | Medicrinia, Co., Ltd. | Composition for regeneration of human fibrous cartilage or elastic cartilage |
| US11116561B2 (en) | 2018-01-24 | 2021-09-14 | Medtronic Ardian Luxembourg S.A.R.L. | Devices, agents, and associated methods for selective modulation of renal nerves |
| CN109021166A (zh) * | 2018-07-03 | 2018-12-18 | 北京理工大学 | 一种简易快速制备高粘附作用力水凝胶双层膜的方法 |
| US10869950B2 (en) | 2018-07-17 | 2020-12-22 | Hyalex Orthopaedics, Inc. | Ionic polymer compositions |
| JP2020055916A (ja) * | 2018-09-28 | 2020-04-09 | Ｓｐｉｂｅｒ株式会社 | モールド成形体、モールド成形体の製造方法、およびモールド成形体の柔軟性調整方法 |
| CN109589455B (zh) * | 2018-11-07 | 2022-02-15 | 山东大学第二医院 | 一种热变性胶原蛋白或热变性真皮支架替代物及制备方法 |
| CN109481730B (zh) * | 2018-11-27 | 2021-10-26 | 五邑大学 | 海藻酸钙/聚乙二醇(二醇)二丙烯酸酯三维纤维网络凝胶及其制备方法和应用 |
| JP7198529B2 (ja) * | 2018-11-30 | 2023-01-04 | ネクストバイオメディカル カンパニー リミテッド | 生分解性高分子を含む化学塞栓用水和ゲル粒子 |
| CN111481735A (zh) * | 2019-01-25 | 2020-08-04 | 华中科技大学同济医学院附属协和医院 | 一种医用抗菌护创水凝胶敷料及其制备方法 |
| EP3965837B1 (en) * | 2019-05-07 | 2025-11-26 | Roquette Freres | Novel polysaccharide-based hydrogel scaffolds for wound care |
| KR102786565B1 (ko) * | 2019-07-19 | 2025-03-24 | 주식회사 엘지화학 | 상호 침투형 구조 비드 및 그 제조 방법 |
| KR102740475B1 (ko) * | 2019-07-19 | 2024-12-06 | 주식회사 엘지화학 | 상호 침투형 구조 비드 및 그 제조 방법 |
| CN110448727B (zh) * | 2019-09-17 | 2021-10-19 | 南通大学 | 一种粘性水凝胶材料、免缝合人工神经导管及其制备方法 |
| CN110760076B (zh) * | 2019-11-06 | 2022-04-08 | 大连理工大学 | 一种基于胶体颗粒-iPRF双网络结构的可注射、高强度复合水凝胶及其制备方法和应用 |
| CN110743038B (zh) * | 2019-11-06 | 2021-09-10 | 大连理工大学 | 一种双网络结构复合水凝胶及其制备方法和应用 |
| CN112108083A (zh) * | 2020-09-09 | 2020-12-22 | 江南大学 | 一种n-烷基乳糖胺表面活性剂小分子水凝胶及其制备方法 |
| EP4247446A4 (en) * | 2020-11-18 | 2024-10-02 | The University of British Columbia | Protein hydrogels and methods for their preparation |
| CN113134113B (zh) * | 2021-04-07 | 2022-07-01 | 赛克赛斯生物科技股份有限公司 | 可吸收止血流体明胶的制备方法及可吸收止血流体明胶 |
| WO2022272107A1 (en) * | 2021-06-24 | 2022-12-29 | Rvo 2.0, Inc, D/B/A Optics Medical | Corneal inlay implant |
| WO2022272090A1 (en) * | 2021-06-24 | 2022-12-29 | Rvo 2.0, Inc, D/B/A Optics Medical | Hydrogel composition and methods of use |
| CN114381083B (zh) * | 2021-12-17 | 2023-03-24 | 浙江理工大学上虞工业技术研究院有限公司 | 一种角膜接触镜用抗菌抗氧化水凝胶及其制备方法 |
| CN114716724B (zh) * | 2022-03-16 | 2023-08-22 | 华南理工大学 | 一种基于墨鱼骨的仿生智能水凝胶及其制备方法 |
| CN114796620B (zh) * | 2022-04-24 | 2023-09-29 | 广东顺德工业设计研究院(广东顺德创新设计研究院) | 一种用作医用植入材料的互穿网络水凝胶及其制备方法和应用 |
| CN114773692B (zh) * | 2022-06-20 | 2022-09-27 | 北京智枢生物科技有限公司 | 一种可长期控制ngf释放的活性生物凝胶及其应用 |
| CN116392397B (zh) * | 2023-04-13 | 2024-05-31 | 四川大学 | 一种光响应排龈材料及制备方法和应用 |
| JPWO2024219027A1 (enExample) * | 2023-04-21 | 2024-10-24 | ||
| CN116985489B (zh) * | 2023-07-18 | 2025-05-30 | 郑州大学 | 一种智能响应的双层水凝胶及其制备方法和应用 |
| CN117467074B (zh) * | 2023-10-23 | 2024-07-12 | 苏州健雄职业技术学院 | 一种基于两性离子聚合物凝胶的生物降解纳米酶的制备与应用 |
Family Cites Families (34)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4388428A (en) | 1981-07-20 | 1983-06-14 | National Patent Development Corporation | Biologically stabilized compositions comprising collagen as the major component with ethylenically unsaturated compounds used as contact lenses |
| US4452929A (en) | 1983-09-09 | 1984-06-05 | Celanese Corporation | Water reducible epoxy based coating compositions |
| JPS6145765A (ja) * | 1984-08-07 | 1986-03-05 | 宇部興産株式会社 | 血管補綴物及びその製造方法 |
| US4731078A (en) * | 1985-08-21 | 1988-03-15 | Kingston Technologies Limited Partnership | Intraocular lens |
| US5112350A (en) * | 1986-10-16 | 1992-05-12 | Cbs Lens, A California General Partnership | Method for locating on a cornea an artificial lens fabricated from a collagen-hydrogel for promoting epithelial cell growth and regeneration of the stroma |
| US5114627A (en) * | 1986-10-16 | 1992-05-19 | Cbs Lens | Method for producing a collagen hydrogel |
| BR9007643A (pt) * | 1989-09-15 | 1992-08-18 | Chiron Ophthalmics Inc | Metodo para se conseguir a epitelizacao de lentes sinteticas |
| US5112250A (en) * | 1991-05-31 | 1992-05-12 | Wang Tsan Chi | T-type coaxial cable connector |
| IT1260154B (it) * | 1992-07-03 | 1996-03-28 | Lanfranco Callegaro | Acido ialuronico e suoi derivati in polimeri interpenetranti (ipn) |
| US5632773A (en) * | 1994-05-03 | 1997-05-27 | Allergan, Inc. | Biostable corneal implants |
| US5518732A (en) * | 1995-02-14 | 1996-05-21 | Chiron Vision, Inc. | Bio-erodible ophthalmic shield |
| EP1704878B1 (en) * | 1995-12-18 | 2013-04-10 | AngioDevice International GmbH | Crosslinked polymer compositions and methods for their use |
| US5746633A (en) * | 1996-01-22 | 1998-05-05 | Jeffrey; Lawrence W. | Personal flotation device |
| US5718012A (en) * | 1996-05-28 | 1998-02-17 | Organogenesis, Inc. | Method of strength enhancement of collagen constructs |
| CN1176272A (zh) * | 1996-09-12 | 1998-03-18 | 翟光远 | 蓖麻油型互穿网络聚合物的制备方法 |
| CN1102614C (zh) * | 1996-12-20 | 2003-03-05 | 香港中文大学 | 新型高分子凝胶体及其应用 |
| US6030634A (en) * | 1996-12-20 | 2000-02-29 | The Chinese University Of Hong Kong | Polymer gel composition and uses therefor |
| US6224893B1 (en) * | 1997-04-11 | 2001-05-01 | Massachusetts Institute Of Technology | Semi-interpenetrating or interpenetrating polymer networks for drug delivery and tissue engineering |
| US6113629A (en) * | 1998-05-01 | 2000-09-05 | Micrus Corporation | Hydrogel for the therapeutic treatment of aneurysms |
| US6899889B1 (en) * | 1998-11-06 | 2005-05-31 | Neomend, Inc. | Biocompatible material composition adaptable to diverse therapeutic indications |
| US20030020870A1 (en) * | 2001-06-27 | 2003-01-30 | Zms, Llc | Biomedical molding materials from semi-solid precursors |
| TW574302B (en) * | 2001-08-10 | 2004-02-01 | Ind Tech Res Inst | A method for producing cross-linked hyaluronic acid-protein bio-composites |
| US6552172B2 (en) * | 2001-08-30 | 2003-04-22 | Habto Biotech, Inc. | Fibrin nanoparticles and uses thereof |
| AU2003234159A1 (en) * | 2002-04-22 | 2003-11-03 | Purdue Research Foundation | Hydrogels having enhanced elasticity and mechanical strength properties |
| JP2005532094A (ja) * | 2002-06-18 | 2005-10-27 | ザ・ボード・オブ・トラスティーズ・オブ・ザ・レランド・スタンフォード・ジュニア・ユニバーシティ | 人工角膜 |
| US7476398B1 (en) * | 2002-06-28 | 2009-01-13 | Universite Laval | Corneal implant and uses thereof |
| US20060134050A1 (en) * | 2002-08-09 | 2006-06-22 | May Griffith | Bio-synthetic matrix and uses thereof |
| US20040147016A1 (en) * | 2002-09-30 | 2004-07-29 | Rowley Jonathan A. | Programmable scaffold and methods for making and using the same |
| US7279174B2 (en) * | 2003-05-08 | 2007-10-09 | Advanced Cardiovascular Systems, Inc. | Stent coatings comprising hydrophilic additives |
| CA2430185A1 (en) * | 2003-05-28 | 2004-11-28 | Heather D. Sheardown | Ophthalmic biomaterials and preparation thereof |
| WO2005113608A1 (en) * | 2004-05-20 | 2005-12-01 | Mentor Corporation | Method of covalently linking hyaluronan and chitosan |
| KR101298442B1 (ko) * | 2004-08-13 | 2013-08-22 | 내셔날 리서치 카운실 오브 캐나다 | 안과용 장치 및 이와 관련된 방법 및 조성물 |
| US7857849B2 (en) * | 2004-10-05 | 2010-12-28 | The Board Of Trustees Of The Leland Stanford Junior Iniversity | Artificial corneal implant |
| US20060287721A1 (en) * | 2004-10-05 | 2006-12-21 | David Myung | Artificial cornea |
-
2006
- 2006-09-11 AU AU2006289625A patent/AU2006289625B2/en not_active Ceased
- 2006-09-11 US US12/066,255 patent/US20080317818A1/en not_active Abandoned
- 2006-09-11 SG SG10201807556TA patent/SG10201807556TA/en unknown
- 2006-09-11 CN CN200680041970XA patent/CN101305052B/zh not_active Expired - Fee Related
- 2006-09-11 WO PCT/CA2006/001520 patent/WO2007028258A2/en not_active Ceased
- 2006-09-11 EP EP06790690A patent/EP1934289A4/en not_active Withdrawn
- 2006-09-11 KR KR1020087008620A patent/KR101382083B1/ko not_active Expired - Fee Related
- 2006-09-11 SG SG201006348-5A patent/SG165337A1/en unknown
- 2006-09-11 JP JP2008529440A patent/JP2009507110A/ja active Pending
- 2006-09-11 CA CA2621824A patent/CA2621824C/en not_active Expired - Fee Related
- 2006-09-11 EP EP12005906A patent/EP2535041A1/en not_active Withdrawn
-
2012
- 2012-11-02 JP JP2012242985A patent/JP5661722B2/ja not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| US20080317818A1 (en) | 2008-12-25 |
| KR101382083B1 (ko) | 2014-04-10 |
| JP2009507110A (ja) | 2009-02-19 |
| EP2535041A1 (en) | 2012-12-19 |
| WO2007028258A2 (en) | 2007-03-15 |
| KR20080065973A (ko) | 2008-07-15 |
| JP5661722B2 (ja) | 2015-01-28 |
| WO2007028258A3 (en) | 2007-11-08 |
| CN101305052A (zh) | 2008-11-12 |
| AU2006289625A1 (en) | 2007-03-15 |
| EP1934289A2 (en) | 2008-06-25 |
| JP2013039425A (ja) | 2013-02-28 |
| CN101305052B (zh) | 2012-10-10 |
| EP1934289A4 (en) | 2011-07-20 |
| SG10201807556TA (en) | 2018-10-30 |
| CA2621824A1 (en) | 2007-03-15 |
| AU2006289625B2 (en) | 2013-08-29 |
| SG165337A1 (en) | 2010-10-28 |
| HK1125395A1 (en) | 2009-08-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2621824C (en) | Interpenetrating networks, and related methods and compositions | |
| Shen et al. | Dual-crosslinked regenerative hydrogel for sutureless long-term repair of corneal defect | |
| CA2576308C (en) | Ophthalmic devices and related methods and compositions | |
| Rosenquist et al. | An injectable, shape-retaining collagen hydrogel cross-linked using thiol-maleimide click chemistry for sealing corneal perforations | |
| JP2008093451A (ja) | 眼用インプラント | |
| CN108601861B (zh) | 复合胶原水凝胶材料、包含该材料的植入式眼科装置和制造该材料和该装置的方法 | |
| JP2013039425A5 (enExample) | ||
| US10273287B2 (en) | Collagen mimetic peptide | |
| US20120071580A1 (en) | Suturable Hybrid Superporous Hydrogel Keratoprosthesis for Cornea | |
| Long et al. | Collagen–hydroxypropyl methylcellulose membranes for corneal regeneration | |
| Sun et al. | Construction and evaluation of collagen-based corneal grafts using polycaprolactone to improve tension stress | |
| US20160144069A1 (en) | Suturable hybrid superporous hydrogel keratoprosthesis for cornea | |
| HK1125395B (en) | Interpenetrating networks, and related methods and compositions | |
| US20230355844A1 (en) | Electrospun Reinforced Suturable Artificial Cornea and Uses Thereof | |
| Pires Moedas De Almeida Barroso | Development of photosensitive biopolymers for ocular tissue engineering | |
| Deng et al. | Photocurable hybrid hydrogels based on gelatin and polysaccharides for sutureless repair of corneal defects | |
| MX2007001630A (en) | Vision enhancing ophthalmic devices and related methods and compositions | |
| HK1078886B (en) | Bio-synthetic matrix and uses thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request | ||
| MKLA | Lapsed |
Effective date: 20210913 |